Martin Joseph Joyce - 04 Jun 2024 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALDX	Stock Option (Right to Buy)	Award	$0	+40,282	$0.000000	40,282	04 Jun 2024	Common Stock	40,282	$4.09	Direct	F1
transaction	ALDX	Stock Option (Right to Buy)	Award	$0	+1,215	$0.000000	1,215	04 Jun 2024	Common Stock	1,215	$4.09	Direct	F2
transaction	ALDX	Stock Option (Right to Buy)	Award	$0	+5,209	$0.000000	5,209	04 Jun 2024	Common Stock	5,209	$4.09	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2	Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.
F3	Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.